Wyeth Rapamune Off-Label Marketing Settlement Will Not Alter Pfizer’s CIA

Pfizer subsidiary to pay $490.9 million to resolve criminal and civil liability for marketing its immunosuppressive for unapproved uses; actions predate Pfizer’s 2009 corporate integrity agreement.